Painless AAS Injection: Subcutaneous Approach

Many enhanced athletes resist the use of injectable Anabolic Androgenic Steroids (AAS) due to the fear of pain—both during the injection and the post-injection pain (PIP). The pain experienced can vary based on several factors, including the needle's thickness, injection site, technique, and the compound itself. However, a virtually painless method exists: the subcutaneous injection, familiar to those who've injected peptides.

Key Differences: Subcutaneous vs Intramuscular Injections

  1. Volume: Intramuscular injections can accommodate a larger volume of oil, allowing for up to 1ml or more at once, which isn’t feasible with subcutaneous injections due to the discomfort and visible oil accumulation it would cause.
  2. Absorption Time: The body absorbs AAS more slowly when injected subcutaneously, affecting the frequency of injections needed and altering the compounds' theoretical half-life in the body.

Guidelines for Subcutaneous AAS Injections:

  1. Frequency & Volume: Rather than adhering strictly to AAS half-life, opt for smaller, more frequent doses, staying under 0.5ml per injection, to avoid visible oil accumulation and discomfort. For example, inject 50mg daily or 100mg every other day instead of 250mg every 5 days.
  2. Needle Size: Use thin insulin needles (28g to 31g, ½ inch length) as they are more comfortable, but be patient as the oil will take time to pass through the needle due to its thickness.
  3. Injection Sites: Rotate between different parts of the lower belly region to avoid discomfort and ensure proper absorption.

Considerations:

  • Patience: Be prepared for slower oil passage through the needle, requiring upwards of 30 seconds for completion.
  • Absorption Time: Understand that the absorption time is slow, and it may take longer for the compound to build up and exhibit its effects, altering the practical application of the theoretical half-life.
  • Effectiveness: While intramuscular injections are conventionally deemed more effective and convenient, subcutaneous injections can be a suitable starting point for those new to AAS or those apprehensive about injections, especially for those using only Testosterone.

Conclusion:

The fear of injection pain is a significant barrier for many considering AAS. The subcutaneous approach offers a less painful alternative, but it requires adjustments in injection frequency and dosage due to its distinct absorption dynamics. Although intramuscular injections are more conventional and arguably more effective, the subcutaneous route can serve as a valuable initiation point, alleviating the apprehension surrounding injections, and providing a gentler introduction to AAS use.